Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. - Wikidata - wikimedia - TriplyDB

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

http://www.wikidata.org/entity/Q43900636

about

Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease Tiotropium for stable chronic obstructive pulmonary disease A rational approach to single, dual and triple therapy in COPD Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis Predicting chronic obstructive pulmonary disease hospitalizations based on concurrent influenza activity Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.COPD exacerbations. 4: Prevention Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.Comparing methods of data synthesis: re-estimating parameters of an existing probabilistic cost-effectiveness model.Tiotropium (Spiriva): a once-daily inhaled anticholinergic medication for chronic obstructive pulmonary disease Inhaled anticholinergic drugs and risk of acute urinary retention.Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.Association between lung function and exacerbation frequency in patients with COPD.Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease Muscarinic receptor signaling in the pathophysiology of asthma and COPD.Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.Management of an acute exacerbation of copd: are we ignoring the evidence?Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.Advances in the management of chronic obstructive pulmonary disease.Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease * 12: New treatments for COPD Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial A bibliometric analysis of the 100 most influential papers on COPD Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation.Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.

P2860

Q21257191-147C6FD9-E682-49E2-A826-FA88DFDB3393 Q24187073-D1FFA92D-4ED1-42E5-88B2-051468D190BD Q24198068-BD5281DD-595E-4F86-BF35-21F722844061 Q24200476-5520ACEC-6352-4D15-B932-F6A0B831BF7C Q24246991-10A48186-1C47-4177-BBC1-2026BD240721 Q26776477-AF2234F1-B8A9-4A48-9A2F-B3ABEB12FD8D Q28070274-063F8AFF-5DB7-49F0-8F26-A2E9586B350F Q28070325-A1D50FD2-47CD-41D3-AA55-2C8D319FEDF8 Q30432654-44C8FE10-CE59-40D1-A033-E2C35A1C44DF Q30478617-F5246090-9099-4283-B16B-D28DE6885961 Q30480789-69B2BDF7-299C-469F-8FFF-B169314A0716 Q30620671-04AEC278-FAF0-40F8-B020-00B4E1846074 Q33591899-186BB8ED-AC77-4B63-A007-AF41F307B064 Q33698524-505AA05C-F6B9-438E-B0E5-DCEA18A83225 Q33711672-40261EB9-4FAE-47CE-A818-ED2BBC695A13 Q33766133-24C3D1AE-FDBE-4DFA-BF73-70D0E5A38C49 Q33944981-AEA61306-7B59-4C12-9367-02047FD5EA50 Q34024144-D09512F5-508E-4A8F-9B34-AD80ECB543B4 Q34065963-52268C59-FBBE-43A0-80D4-4DE9E9E8DEAE Q34177358-04F54A47-0106-4661-85D0-40EF115AB07F Q34243574-82208E31-6D6D-401D-B94F-DD2007149EB0 Q34309072-5C5B4B63-58E7-4D01-B75B-268BC9740AC5 Q34432556-1F216F7A-D934-4867-8F24-DF293DF33041 Q34554784-90BD3D0E-7153-486F-B091-1AE213030B75 Q34677811-B51F1FB6-9732-46AC-9F25-9B4D4F04C9C2 Q34684230-2C084108-598D-4D62-9117-BBE1127F2AAA Q34903093-5B9CC84B-545A-4DEE-86CA-0C176A4E6457 Q34938599-BF880CB9-394C-4931-BB6C-5AB81FAA953B Q34944616-BD4CCE00-8ED4-4389-83FA-9C99BF53FF2C Q35057288-7395E409-3786-4B3A-83CC-58110983348D Q35164693-D1975AC5-CB13-42C2-B705-14EB5C4B6EC6 Q35205369-6C09D779-E990-41F7-913E-3266D7D99DE3 Q35208742-0988C54B-1C5A-43E3-AB80-A76F49CF636F Q35215919-CAB2E794-EF29-4A0D-8D6E-5E89301B090B Q35230811-10BB3465-0630-41B0-BD20-41F2A35C12F9 Q35350962-AAA2FA12-5AB4-41AF-8D0A-57897BCA88B8 Q35508561-EAA2EFA7-BA8E-4452-8F56-F72CAB2D1077 Q35520406-C4214488-12B7-41B6-98CB-58FA86D024CE Q35535912-28C118E0-9525-4E6E-A6FE-B168F6B4918F Q35536623-A9FE185A-3B23-4BB3-94DD-40A04E8E0543

P2860

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

http://www.wikidata.org/entity/Q43900636

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

@en

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

@nl

type

label

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

@en

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

@nl

prefLabel

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

@en

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

@nl

P1433

Q43900636-8F8652D8-0097-4208-9D4D-BD9AA58BAC6B

P1476

Q43900636-0D6DDF6C-D5F9-4798-A4B7-C0DED4871AC9

P2093

Q43900636-20201E5E-628B-498E-A990-34F487CD953A

Q43900636-58B1594A-2725-4B44-BA4B-FCF9AC48654B

Q43900636-75C0308A-213A-4DEA-B384-410E0173B3D8

Q43900636-8C594FD5-E996-4753-935C-99E817C5EA8E

Q43900636-93A7EA99-8692-41BD-9640-E66468710B0C

Q43900636-9AC3B93D-AEE6-41EB-A7E1-21D7EF683F34

Q43900636-CFB5BC6A-D64E-4C28-BB7D-5920BB87F38F

Q43900636-FC200E4B-C8E8-4306-BA46-EAD75D54FBCD

P304

Q43900636-EB8350BA-C120-4EB5-8D25-F9DD269CD344

P31

Q43900636-CFDFDAAA-639E-49F9-9D6E-21047B51FB79

P356

Q43900636-E4E7F3C8-B94F-49D8-AFE2-82482726F201

P433

Q43900636-2670C7B7-D17A-4CF1-9B60-B44183AB7ECE

P478

Q43900636-BB8CCF3F-CA26-4715-95D0-D9BC939CF884

P577

Q43900636-A5310344-B1D5-46F8-BE09-A4751A00CAB7

P5875

Q43900636-1C721B87-D2E4-4F83-891B-ABCD42AD5F49

P698

Q43900636-5A8EB55E-04A0-48E2-B638-A65B0E751A40

P356

09031936.02.00238702

P1433

European Respiratory Journal

P1476

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

@en

P2093

A P M Greefhorst

http://www.w3.org/2001/XMLSchema#string

Dutch/Belgian Tiotropium Study Group

http://www.w3.org/2001/XMLSchema#string

J A van Noord

http://www.w3.org/2001/XMLSchema#string

L Korducki

http://www.w3.org/2001/XMLSchema#string

P J G Cornelissen

http://www.w3.org/2001/XMLSchema#string

S Kesten

http://www.w3.org/2001/XMLSchema#string

Th A Bantje

http://www.w3.org/2001/XMLSchema#string

W Vincken

http://www.w3.org/2001/XMLSchema#string

P304

209-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.02.00238702

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11491711

http://www.w3.org/2001/XMLSchema#string

P698

11871363

http://www.w3.org/2001/XMLSchema#string